Crinetics Pharmaceuticals Stock (NASDAQ: CRNX) stock price, news, charts, stock research, profile.
Open | $43.570 |
Close | - |
Volume / Avg. | 93.551K / 810.676K |
Day Range | 42.047 - 44.780 |
52 Wk Range | 15.760 - 49.580 |
Market Cap | $3.385B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 6.92% |
Days to Cover | 4.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Crinetics Pharmaceuticals (NASDAQ: CRNX) through any online brokerage.
Other companies in Crinetics Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
The latest price target for Crinetics Pharmaceuticals (NASDAQ: CRNX) was reported by JMP Securities on Thursday, March 28, 2024. The analyst firm set a price target for 80.00 expecting CRNX to rise to within 12 months (a possible 84.16% upside). 38 analyst firms have reported ratings in the last year.
The stock price for Crinetics Pharmaceuticals (NASDAQ: CRNX) is $43.44 last updated April 22, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.